Physician profile
Douglas Scott Schultz
NPI 1881089043
$4,510.43
in general payments reported to CMS, 2019-2025
9 companies · $1,363 in 2025
The $1,363 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $263 · 2022: $156 · 2023: $332 · 2024: $2,397 · 2025: $1,363.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,233 · Food and Beverage: $1,860.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,232.58 |
| Food and Beverage | $1,859.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $3,534.97 | 2022-2025 | Avenir, Persona, Mymobility Platform |
| Stryker Corporation | $434.62 | 2021-2025 | Mako |
| Medacta USA, INC. | $284.35 | 2025 | Gmk Sphere, Mecta |
| Next Science LLC | $124.76 | 2025 | Blastx, Xperience |
| Boston Scientific Corporation | $53.90 | 2023 | |
| Convatec INC. | $24.32 | 2025 | |
| Depuy Synthes Sales INC. | $22.58 | 2023 | Fibulink, Na, Va-Lcp |
| Heron Therapeutics, INC. | $15.64 | 2022 | |
| Smith+Nephew, INC. | $15.29 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Douglas Schultz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.